IL10 and metabolic syndrome: Statistically significant differences were observed between the groups with and without metabolic syndrome (MetS), even as participants with MetS had reduced serum cytokine levels (p < 0.001; Table 2), regarding the research participants’ clinical status and serum IL-10 concentrations (Table 2).